Freestone Capital Holdings’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$379K Sell
6,974
-27
-0.4% -$1.31K 0.01% 444
2026
Q1
$300K Buy
+7,001
New +$301K 0.01% 440
2020
Q4
Sell
-279
Closed -$6.82K 1294
2020
Q3
$6.82K Buy
+279
New +$6.51K ﹤0.01% 818
2013
Q4
Sell
-18,043
Closed -$87K 325
2013
Q3
$87K Buy
+18,043
New +$93.4K 0.02% 341

Other funds holding EXEL

Freestone Capital Holdings's EXEL Position: Q2 2026 in Review

Freestone Capital Holdings reduced its Exelixis (EXEL) stake by 0.39% in Q2 2026, selling an estimated $1.31K and leaving 6,974 shares worth $379K. The position accounts for 0.01% of the portfolio, ranked #444.

Freestone Capital Holdings first reported a position in EXEL in Q3 2013 and has held it in 4 quarters since. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Freestone Capital Holdings held 6,974 shares of Exelixis worth $379K as of Q2 2026.
  • Freestone Capital Holdings sold 27 Exelixis shares in Q2 2026, an estimated $1.31K.
  • Exelixis made up 0.01% of Freestone Capital Holdings's portfolio in Q2 2026, its #444 holding.
  • Freestone Capital Holdings first reported a position in Exelixis in Q3 2013 and has held it in 4 quarters since.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Freestone Capital Holdings's 13F filing for Q2 2026, filed 31 Jul 2026.